The conditions are probably as good as they're likely to be for those opportunists willing to take the risk of shorting NAN. Such conditions include:
- likely reduction in NAN profit in 2017/18 due to the impact of increased short term expenditure for long term growth, and due to the short term revenue impacts of the MES model strategy in the UK;
- a lead time of up to 20 months before the market gets to assess the nature and potential of the two new products for which NAN is seeking to gain regulatory ticks and then bring to market;
- a lead time of 19 months before NAN enjoys the revenue enhancement expected to flow from the new agreement with GEHC, whereby NAN will takeover consumables resupply for most of the US market, including the GEHC customer base.
zeno9
NAN Price at posting:
$2.55 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)